ZBIO Zenas BioPharma, Inc.
Zenas BioPharma, Inc. (ZBIO) Insider Activity
What the officers, directors and large holders did with their own shares. Only open-market purchases and sales count toward the totals — grants, option exercises and shares withheld for tax are compensation mechanics, not decisions, and they're listed separately below.
Where they traded
Last open-market purchase: May 18, 2026 , by MOULDER LEON O JR .
Recent open-market activity
| Date | Insider | Role | Action | Shares | Price | Value | Held after |
|---|---|---|---|---|---|---|---|
| MOULDER LEON O JR | Chief Executive Officer | Buy | 60,000 | $16.88 | $1.0M | 96,928 | |
| MOULDER LEON O JR | Chief Executive Officer | Buy | 35,000 | $17.62 | $616.7K | 1,786,039 | |
| MOULDER LEON O JR | Chief Executive Officer | Buy | 25,000 | $18.02 | $450.5K | 1,751,039 |
Form 4s are due within two business days of a transaction, so this is close to real time — unlike the quarterly 13F data on the Institutional tab. A single large sale often reflects a prearranged 10b5-1 plan rather than a fresh view, so read a pattern of sales rather than any one of them.